3 Hot Penny Stocks to Watch Right Now
As the first full week of trading penny stocks in September comes to an end, many investors are wondering which small-caps are worth it. And while it is easy to find the biggest gaining penny stocks of the day for your watchlist, buying and selling penny stocks should go beyond this.
Rather than looking at big gainers, investors should consider what’s going on in the world, and how that could help to create the next rally. For example, Covid has resulted in several industries spiking in value in the past few months. While these spikes have become less common with the rise of the Delta variant, they are still around.
This includes energy penny stocks, biotech penny stocks, and tech/entertainment penny stocks among others. Within each of these industries are companies that all offer different value points to investors. So make sure you know everything about the company in question, and how it could move in the near future.
Investing in penny stocks in 2021 is challenging without a doubt. With so many moving parts right now, the market is more volatile than it has been in many months prior. So, stay ahead, and use your strategy as an advantage. Considering all of this, let’s take a look at three penny stocks to add to your September watchlist.
3 Penny Stocks For Your Watchlist in September 2021
Tellurian Inc. (NASDAQ: TELL)
Tellurian Inc. is an energy penny stock that is up by over 128% YTD. In addition, TELL stock is up by over 289% in the past twelve months which is no small feat. For some context, this company operates in the natural gas industry. It is currently developing a portfolio of natural gas production, infrastructure, and liquefied natural gas marketing assets. This includes a 27.6 million tonnes per annum LNG terminal facility. Tellurian owns interests in 9,373 net acres of natural gas production assets and 72 producing wells in total.
Tellurian previously announced an underwritten public offering of $50 million aggregate principal amount of 8.25% senior notes due 2028. Now the company has withdrawn its senior notes offering on August 31st. The company also announced the exercise of a common stock over-allotment option.
“Clearly the massive retail investment market has been disruptive to the old rules guiding institutional investing, first in equities and now in bonds. Of course, we are disappointed with Nasdaq’s decision and wish it would have advised us earlier in the process.”hairman of Tellurian, Charif Souki
Since the company announced its withdrawal from this underwritten public offering, its stock price has gone up in the market. This makes sense as the potential of less share dilution could be a positive for the company. So considering this, will TELL stock make your penny stocks watchlist in September?
Celsion Corporation (NASDAQ: CLSN)
Celsion Corporation is a biotech company that has been pushing up in several recent trading sessions. This company develops and commercializes directed chemotherapies. It is also developing DNA-mediated immunotherapy and vaccines. Currently, Celsion is working on ThermoDox which is in Phase 3 clinical trials to treat primary liver cancer. It is also developing GEN-1 which is in Phase 2 clinical trials to treat ovarian cancers.
Celsion has caught a lot of attention recently with its COVID-19 related developments. Now in September, the company announced its T-cell and B-cell response from In Vivo studies of its PLACCINE DNA vaccine platform. Basically, its vaccine platform has shown serious potential against COVID-19 in these preclinical studies.
The company’s executive VP and Chief Science Officer Khursheed Anwer said, “In an effort to establish a suite of platform technologies, we have produced and characterized a family of DNA vaccine vectors expressing one or more SARS-CoV-2 surface antigens or proteins with or without immune modifiers or agents to improve vaccine quality.”
This news has helped boost CLSN stock upwards in the market. Currently, CLSN stock is experiencing higher than average volume. Keeping this in mind, will CLSN enter your list of penny stocks to watch?
Advaxis Inc. (NASDAQ: ADXS)
While ADXS stock didn’t start the day strong, by midday, shares began to skyrocket, pulling in more than 28% in gains. This brings ADXS’s one-month gain to almost 40% which is no small feat. So, why the major uptick for ADXS stock today? Well, right before the market opened, the biotech company reported its 3rd quarter financial results for the period ending on July 31st.
“We are thrilled by the transformative potential of our proposed merger with Biosight and believe the opportunity to build a diversified clinical pipeline with both early and late-stage oncology assets will benefit both patients and our stockholders.
We expect that the coming months will provide data readouts from our expanded off-the-shelf neoantigen program in both NSCLC and prostate cancer which will build upon our strong foundation of data showing consistent clinical benefit.”CEO and President of Advaxis, Kenneth Berlin
Financially, the company ended the quarter with roughly $45.3 million in cash and cash equivalents. This is a major benefit to the company, as large cash balances offer the potential for short and long-term growth.
In addition, the company stated that it initiated the Phase 1 clinical trial of its compound ADXS-504 for treating prostate cancer. So, all of this positivity could be the main reason behind ADXS stock pushing up during intraday trading today. But, there is also an overwhelming amount of support for biotech stocks right now. Considering this, do you think that ADXS stock is worth adding to your watchlist?
Penny Stocks Continue to Heat Up in September
With September continuing to be a promising month for penny stocks, many investors are looking for the best small-caps to watch. By understanding what’s going on in the market and how to use that to your advantage, traders can have the highest chances of making money with penny stocks.
But, it’s extremely important to understand what type of trader you are. This will help you to avoid investing in stocks that are outside of your comfort levels. Considering all of this, it’s no wonder that penny stocks are continuing to heat up right now.